Akzo Nobel N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AKZOY research report →
Price Chart
About the company
Akzo Nobel N. V. operates as an international corporation, specializing in the creation, production, and distribution of a comprehensive array of paints and protective surface coverings.
- CEO
- Gregoire Poux-Guillaume
- IPO
- 1989
- Employees
- 31,500
- HQ
- Amsterdam, NH, NL
Get TickerSpark's AI analysis on AKZOY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $35.87B
- P/E
- 16.20
- Fwd P/E
- 17.54
- PEG
- 0.31
- P/S
- 1.04
- P/B
- 2.13
- EV/EBITDA
- 8.30
- Div Yield
- 3.28%
- Gross Margin
- 40.70%
- Op Margin
- 9.34%
- Net Margin
- 6.43%
- ROE
- 13.88%
- ROIC
- 4.70%
Latest fiscal year · YoY change
- Revenue
- $9.76B-8.9%
- Gross Profit
- $3.89B-10.3%
- Op Income
- $743.45M
- Net Income
- $609.94M+12.5%
- EPS
- $1.19+12.6%
- OCF Growth
- +31.6%
- FCF Growth
- +60.8%
- 52W High
- $25.99
- 52W Low
- $18.04
- 50D MA
- $22.82
- 200D MA
- $21.85
- Beta
- 1.15
- RSI (14)
- 50
- Avg Volume
- 85.28K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
AkzoNobel delivered 2% organic sales growth and further margin expansion in Q2, while reaffirming full-year EBITDA guidance and keeping the Axalta merger on track.· July 22, 2026
- Organic sales rose 2% year-on-year, with 3% pricing, flat volumes, and a 1% negative mix impact.
- Adjusted gross margin improved to 42.7% and adjusted EBITDA margin to 15.4%, marking the fifth straight quarter of year-on-year margin expansion.
- Adjusted EBITDA was EUR 398 million, up 5% at comparable scope; total revenue was down 1% due to the India liquid business divestment and FX.
- Management left 2026 adjusted EBITDA guidance unchanged at at or above EUR 1,470 million and guided Q3 adjusted EBITDA at around EUR 390 million.
- Cash generation remained solid, with EUR 108 million of free cash flow, trade working capital at 15.6% of revenue, and net leverage at 2.2x.
Q2 total revenue was down 1%, mainly due to the India liquid businesses divestment (3% impact), while organic sales were up 2% year-on-year on 3% pricing and flat volumes with a 1% negative mix effect. Adjusted gross margin was 42.7%, up 70 basis points year-on-year, and adjusted EBITDA margin was 15.4%, up 40 basis points; adjusted EBITDA was EUR 398 million, up 5% at comparable scope. Free cash flow was EUR 108 million, trade working capital improved to 15.6% of revenue (140 basis points below prior year), return on investment was 13.8%, and net leverage was 2.2x. For 2026, adjusted EBITDA guidance remains at or above EUR 1,470 million, with Q3 adjusted EBITDA expected at around EUR 390 million and volumes broadly flat; pricing is expected to build further as raw material inflation flows through, and the full-year free cash flow trajectory was unchanged with working capital expected at 14.5%, CapEx around EUR 300 million, and identified cash outflows around EUR 250 million including merger costs.
Greg Poux-Guillaume emphasized execution, saying the company did what it said it would do: protect margins through pricing, keep volumes stable, and continue cost control. He highlighted that pricing is now fully in place to offset current inflation, with more pricing expected as raw material costs peak in Q3, and said he remains confident about the rest of the year. On strategy, he stressed that the Axalta merger remains on schedule and that the combination has substantial synergy potential, while also noting AkzoNobel reached its 50% Scope 1 and 2 carbon reduction target four years early.
Maarten de Vries focused on the financial bridge: organic sales up 2%, price up 3%, flat volumes, and a 1% mix headwind, with the India disposal and FX weighing on reported revenue. He pointed to EUR 398 million of adjusted EBITDA, a 15.4% margin, EUR 108 million of free cash flow, working capital at 15.6% of revenue, and leverage at 2.2x. He also said full-year working capital should end at 14.5%, CapEx is now expected around EUR 300 million, and identified cash outflows are roughly EUR 250 million, while confirming that full-year free cash flow assumptions were unchanged.
Analysts pressed on Deco disposals, especially Southeast Asia and Europe, and management said the strategy is unchanged: AkzoNobel wants to focus Deco on leadership positions, while Southeast Asia is still under review and Europe is generally not for sale. Questions also focused on Marine and Protective, where management said the softer Q2 was temporary, driven by ships stuck at sea, high day rates, and cautious tendering around raw material trends rather than a structural slowdown. Other questions covered pricing versus raw materials, with management saying pricing had reached 3% in Q2 and should rise further in H2, and cash flow, where CFO said no change to full-year FCF guidance despite merger-related cash costs.
The quarter showed both growth and margin expansion, with pricing ahead of inflation and volumes resilient, suggesting the company is managing a volatile backdrop effectively. Management also reiterated full-year EBITDA guidance and described the Axalta merger as progressing on schedule with more than $600 million of identified cost synergies and additional revenue synergies.
Q2 volume growth was uneven, with Deco down 4% and China still pressured by the real estate market, while Marine was softer due to temporary shipping disruptions and cautious customer behavior. The company also flagged continued volatility in raw materials and logistics, ongoing merger-related execution risk, and uncertainty around Russia, which has been deconsolidated after state administration actions.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 95.0%
- Shares Outstanding
- 1.54B
- Float Shares
- 1.46B
Congressional trading
Senate and House stock disclosures for AKZOY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Jul 10, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Held by 7 ETFs
Biggest fund positions in AKZOY by dollar value.
Our AKZOY coverage
Recent articles, reports, and earnings notes.
No research on AKZOY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AKZOY report →AKZOY or APD: Which Is the Better Value Stock Right Now?
zacks.com · Aug 7
AkzoNobel (AKZOY) Upgraded to Buy: Here's What You Should Know
zacks.com · Aug 4
Akzo Nobel N.V. (AKZOY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 22
Nippon Paint Makes $8.6 Billion Bid for AkzoNobel's Decorative-Paints Unit
wsj.com · Jul 13
Nippon Paint said to offer $8.6 billion for Akzo Nobel's paint arm, Bloomberg News reports
reuters.com · Jul 12
AkzoNobel Shares Plunge After Sherwin-Williams, Nippon Paint Drop $14.5 Billion Bid
wsj.com · Jun 3
Nippon Paint Group and Sherwin-Williams End Pursuit of AkzoNobel
prnewswire.com · Jun 3
New Strong Sell Stocks for May 29th
zacks.com · May 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.